1,282
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Asthma prevalence and exacerbations in children: is there an association with childhood vaccination?

Pages 687-694 | Published online: 10 Jan 2014

References

  • Rottem M, Shoenfeld Y. Vaccination and allergy. Curr. Opin. Otolaryngol. Head Neck Surg.12, 223–231 (2004).
  • Bohlke K, Davis RL, Marcy SM et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics112, 815–820 (2003).
  • Eggleston PA. Asthma. In: Oski’s Pediatrics, 4th Edition. McMillan JA, Feigin RD, DeAngelis C, Jones MD (Eds). Lippincott Williams & Wilkins, PA, USA (2006).
  • Tan WC. Viruses in asthma exacerbations. Curr. Opin. Pulm. Med.11, 21–26 (2005).
  • Heymann PW, Platts-Mills TAE, Johnston SL. Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults. Pediatr. Infect. Dis. J.24, 217–222 (2005).
  • Glezen WP. Asthma, influenza, and vaccinations. J. Allergy Clin. Immunol.118, 1199–1206 (2006).
  • Romanowska M, Rybicka K, Nowak I et al. Antibody response to influenza vaccination in patients suffering from asthma. J. Physiol. Pharmacol.58(Suppl. 5 Pt 2), 583–589 (2007).
  • Koppen S, de Groot R, Neijens HJ, Nagelkerke N, van Eden W, Rümke HC. No epidemiologic evidence for infant vaccinations to cause allergic diseases. Vaccine22(25–26), 3375–3378 (2004).
  • Sanchez-Solis M, Garcia-Marcos L. Do vaccines modify the prevalence of asthma and allergies? Expert Rev. Vaccines5(5), 631–640 (2006).
  • The American Lung Association Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N. Engl. J. Med.345(21), 1529–1536 (2001).
  • Zeiger RS. Current issues with influenza vaccination in egg allergy. J. Allergy Clin. Immunol.110(6), 834–840 (2002).
  • Keenan H, Campbell J, Evans PH. Influenza vaccination in patients with asthma: why is the uptake so low? Br. J. Gen. Pract.57(538), 359–363 (2007).
  • Kmiecik T, Sek K, Górski P. [Safety of influenza vaccination in asthmatics]. Pneumonol. Alergol. Pol.74(4), 365–371 (2006).
  • Park CL, Frank A. Does influenza vaccination exacerbate asthma? Drug Saf.19(2), 83–88 (1998).
  • Kramarz P, Destefano F, Gargiullo PM et al. Does influenza vaccination prevent asthma exacerbations in children? J. Pediatr.138(3), 306–310 (2001).
  • Tata LJ, West J, Harrison T, Farrington P, Smith C, Hubbard R. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax58(10), 835–839 (2003).
  • Miller RL, Cheng M, DiMango EA, Geromanos K, Rothman PB. American Lung Association Asthma Clinical Research Centers. T-cell responses and hypersensitivity to influenza and egg antigens among adults with asthma immunized with the influenza vaccine. J. Allergy Clin. Immunol.112(3), 606–608 (2003).
  • Kmiecik T, Arnoux S, Kobryn A, Gorski P. Influenza vaccination in adults with asthma: safety of an inactivated trivalent influenza vaccine. J. Asthma44(10), 817–822 (2007).
  • Bergen R, Black S, Shinefield H et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr. Infect. Dis.23, 138–144 (2004).
  • Fleming DM, Crovari P, Wahn U et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr. Infect. Dis. J.25(10), 860–869 (2006).
  • Ashkenazi S, Vertruyen A, Arístegui J et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr. Infect. Dis. J.25(10), 870–879 (2006).
  • Belshe RB, Edwards KM, Vesikari T et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N. Engl. J. Med.356(7), 685–696 (2007).
  • Gaglani MJ, Piedra PA, Riggs M, Herschler G, Fewlass C, Glezen WP. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial. Pediatr. Infect. Dis. J.27(5), 444–452 (2008).
  • Redding G, Walker RE, Hessel C et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr. Infect. Dis. J.21(1), 44–48 (2002).
  • Cates CJ, Jefferson TO, Rowe BH. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev.2, CD000364 (2008).
  • Minne A, Jaworska J, Gerhold K, et al. Intranasal delivery of whole influenza vaccine prevents subsequent allergen-induced sensitization and airway hyper-reactivity in mice. Clin. Exp. Allergy37(8), 1250–1258 (2007).
  • Fiore AE, Shay DK, Broder K et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm. Rep.57(RR-7), 1–60 (2008).
  • American Academy of Pediatrics Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2007–2008. Pediatrics121(4), E1016–E1031 (2008).
  • Herz U, Gerhold K, Grüber C et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J. Allergy Clin. Immunol.102(5), 867–874 (1998).
  • von Mutius E, Pearce N, Beasley R et al. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax55(6), 449–453 (2000).
  • Grüber C, Meinlschmidt G, Bergmann R, Wahn U, Stark K. Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds. Pediatr. Allergy Immunol.13, 177–181 (2002).
  • Choi IS, Koh YI. Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. Ann. Allergy Asthma Immunol.88(6), 584–591 (2002).
  • Marks GB, Ng K, Zhou J et al. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J. Allergy Clin. Immunol.111(3), 541–549 (2003).
  • Aaby P, Shaheen SO, Heyes CB et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin. Exp. Allergy30(5), 644–650 (2000).
  • Krause TG, Hviid A, Koch A et al. BCG vaccination and risk of atopy. JAMA289(8), 1012–1015 (2003).
  • Mommers M, Weishoff-Houben M, Swaen GM et al. Infant immunization and the occurrence of atopic disease in Dutch and German children: a nested case–control study. Pediatr. Pulmonol.38(4), 329–434 (2004).
  • García-Marcos L, Morales Suárez-Varela M, Miner Canflanca I et al. BCG immunization at birth and atopic diseases in a homogenous population of Spanish schoolchildren. Int. Arch. Allergy Immunol.137, 303–309 (2005).
  • Linehan MF, Frank TL, Hazell ML et al. Is the prevalence of wheeze in children altered by neonatal BCG vaccination? J. Allergy Clin. Immunol.119(5), 1079–1085 (2007).
  • Li J, Zhou Z, An J, Zhang C, Sun B, Zhong N. Absence of relationships between tuberculin responses and development of adult asthma with rhinitis and atopy. Chest133(1), 100–106 (2008).
  • Balicer RD, Grotto I, Mimouni M, Mimouni D. Is childhood vaccination associated with asthma? A meta-analysis of observational studies. Pediatrics120(5), E1269–E1277 (2007).
  • Nilsson L, Kjellman NI, Björkstén B. A randomized controlled trial of the effect of pertussis vaccines on atopic disease. Arch. Pediatr. Adolesc. Med.152(8), 734–738 (1998).
  • Nilsson L, Kjellman NI, Bjorksten B. Allergic disease at the age of 7 years after pertussis vaccination in infancy: results from the follow-up of a randomized controlled trial of 3 vaccines. Arch. Pediatr. Adolesc. Med.157, 1184–1189 (2003).
  • Bernsen RM, de Jongste JC, van der Wouden JC. Lower risk of atopic disorders in whole cell pertussis-vaccinated children. Eur. Respir. J.22, 962–964 (2003).
  • Maitra A, Sherriff A, Griffiths M, Henderson J; Avon Longitudinal Study of Parents and Children Study Team. Pertussis vaccination in infancy and asthma or allergy in later childhood: birth cohort study. BMJ328, 925–926 (2004).
  • DeStefano F, Gu D, Kramarz P et al. Childhood vaccinations and risk of asthma. Pediatr. Infect. Dis. J.21, 498–504 (2002).
  • Grüber C, Illi S, Lau S et al. Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics111(3), E282–E288 (2003).
  • Bernsen RM, Nagelkerke NJ, Thijs C, van der Wouden JC. Reported pertussis infection and risk of atopy in 8- to 12-yr-old vaccinated and non-vaccinated children. Pediatr. Allergy Immunol.19(1), 46–52 (2008).
  • Ponvert C, Ardelean-Jaby D, Colin-Gorski AM et al. Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case–control study based on immediate responses in skin tests and specific IgE determination. Vaccine19(32), 4588–4591 (2001).
  • Destefano F, Pfeifer D, Nohynek H. Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data. Bull. World Health Organ.86(5), 373–380 (2008).
  • Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N. Engl. J. Med.349, 1341–1348 (2003).
  • Roost HP, Gassner M, Grize L et al. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren. Pediatr. Allergy Immunol.15(5), 401–407 (2004).
  • Bernsen RM, Koes BW, de Jongste JC, van der Wouden JC. Haemophilus influenzae type b vaccination and reported atopic disorders in 8–12-year-old children. Pediatr. Pulmonol.41(5), 463–469 (2006).
  • Anderson HR, Poloniecki JD, Strachan DP et al. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am. J. Public Health91(7), 1126–1129 (2001).
  • Sakaguchi M, Inouye S. IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria–tetanus–acellular pertussis (DTaP) vaccines. Vaccine18(19), 2055–2058 (2000).
  • Kumagai T, Ozaki T, Kamada M et al. Gelatin-containing diphtheria–tetanus–pertussis (DTP) vaccine causes sensitization to gelatin in the recipients. Vaccine18(15), 1555–1561 (2000).
  • Zeiger RS. Current issues with influenza vaccination in egg allergy. J. Allergy Clin. Immunol.110, 834–840 (2002).
  • James JM, Zeiger RS, Lestor MR et al. Safe administration of influenza vaccine to patients with egg allergy. J. Pediatr.133, 624–628 (1998).
  • Kroger AT, Atkinson WL, Marcuse EK et al. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.55(RR-15), 1–48 (2006).
  • Bueving HJ, van der Wouden JC. What is the role of virus vaccination in patients with asthma? Curr. Allergy Asthma Rep.7(1), 72–76 (2007).
  • Bueving HJ, Bernsen RM, de Jongste JC et al. Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am. J. Respir. Crit. Care Med.169(4), 488–493 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.